Rights and permissions
About this article
Cite this article
Acne prescribing moving towards isotretinoin, worth the extra risk. Pharmacoecon. Outcomes News 492, 12 (2005). https://doi.org/10.2165/00151234-200504920-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504920-00027